CAS RN: 139504-50-0

Mertansine

Product Availability

Choose a grade to view its available package options.

13 package records13 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260131 100mg In stock Shanghai, Tianjin Inquiry
Batchno.20251220 10mg In stock Shanghai Inquiry
Batchno.20260503 1g In stock Shanghai, Chengdu Inquiry
Batchno.20250601 1mg In stock Shanghai Inquiry
Batchno.20250930 250mg In stock Shanghai Inquiry
Batchno.20250418 25mg In stock Shanghai Inquiry
Batchno.20260222 2mg In stock Shanghai Inquiry
Batchno.20260212 50mg In stock Shanghai, Tianjin Inquiry
Batchno.20250929 5mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250615 100mg In stock Shandong Inquiry
Batchno.20260403 10mg In stock Shanghai, Shandong Inquiry
Batchno.20250629 25mg In stock Hebei Inquiry
Batchno.20250807 5mg In stock Shanghai, Shandong, Guangdong, Hebei Inquiry
  • Product code: SSC-050145
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 0.25g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 139504-50-0
Pack Size Recorded Purity Available Qty Ship From Inquiry
0.25g ≥95% 0 Out of Stock Beijing Inquiry

139504-50-0 / [(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] (2S)-2-[methyl(3-sulfanylpropanoyl)amino]propanoate

Standard CAS: 139504-50-0 Multi CAS: No

Basic Information

CAS
139504-50-0
Multi CAS
No
Molecular Formula
C35H48ClN3O10S
Molecular Weight
738.300000
Exact Mass
737.274894
SMILES
C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C/C=C(/CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)OC(=O)[C@H](C)N(C)C(=O)CCS)C)\C)OC)(NC(=O)O2)O
InChI
InChI=1S/C35H48ClN3O10S/c1-19-10-9-11-26(46-8)35(44)18-25(47-33(43)37-35)20(2)31-34(4,49-31)27(48-32(42)21(3)38(5)28(40)12-13-50)17-29(41)39(6)23-15-22(14-19)16-24(45-7)30(23)36/h9-11,15-16,20-21,25-27,31,44,50H,12-14,17-18H2,1-8H3,(H,37,43)/b11-9+,19-10+/t20-,21+,25+,26-,27+,31-,34+,35+/m1/s1
InChIKey
ANZJBCHSOXCCRQ-WPIRGBRYSA-N

Computed Properties

Structural Parameters

Heavy atom count
50
Aromatic heavy atom count
6
Fraction Csp3
0.6
Rotatable bonds
7
H-bond acceptors
11
H-bond donors
3
Molar refractivity
189.42
TPSA
156.47

LogP / Solubility

WLOGP
3.83
MLOGP
3.44
XLogP3
2.2
Consensus LogP
3.16
Log S (ESOL)
-6.46
Class (ESOL)
Insoluble
Log S (Ali)
-8.38
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-8.48
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-4.5

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Safety & Transport

Pictogram(s)
Corrosive Acute Toxic Health Hazard
Signal
Danger
GHS Hazard Statements
H300 (50%): Fatal if swallowed [Danger Acute toxicity, oral] H310 (75%): Fatal in contact with skin [Danger Acute toxicity, dermal] H314 (75%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] H340 (75%): May cause genetic defects [Danger Germ cell mutagenicity] H341 (25%): Suspected of causing genetic defects [Warning Germ cell mutagenicity]
Precautionary Statement Codes
P203, P260, P262, P264, P270, P280, P301+P316, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P308+P316, P316, P318, P319, P321, P330, P361+P364, P363, P405, and P501

Get In Touch

Contact Us